The clinical program of CLL is rather heterogeneous, starting from a reasonably asymptomatic disorder that will even regress spontaneously into a progressive ailment that sooner or later contributes to the individual’s Loss of life, so there has usually been outstanding interest in pinpointing the prognosis of particular person sufferers. Though